The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

TABUTEAU HERRIOT

Reporting owner CIK 0001219927 · Chief Executive Officer · Director · 10% owner

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.TABUTEAU HERRIOTTABUTEAU HERRIOTTABUTEAU HERRIOT · December 4, 2025 · Exercise / conversion · Common StockTABUTEAU HERRIOT · December 3, 2025 · Exercise / conversion · Common StockTABUTEAU HERRIOT · December 2, 2025 · Exercise / conversion · Common StockTABUTEAU HERRIOT · November 5, 2025 · Exercise / conversion · Common StockTABUTEAU HERRIOT · November 4, 2025 · Exercise / conversion · Common StockTABUTEAU HERRIOT · November 3, 2025 · Exercise / conversion · Common StockNov 3, 2025Dec 4, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 4, 2025Axsome Therapeutics, Inc.Common StockTABUTEAU HERRIOTExercise / conversion
Dec 3, 2025Axsome Therapeutics, Inc.Common StockTABUTEAU HERRIOTExercise / conversion
Dec 2, 2025Axsome Therapeutics, Inc.Common StockTABUTEAU HERRIOTExercise / conversion
Nov 5, 2025Axsome Therapeutics, Inc.Common StockTABUTEAU HERRIOTExercise / conversion
Nov 4, 2025Axsome Therapeutics, Inc.Common StockTABUTEAU HERRIOTExercise / conversion
Nov 3, 2025Axsome Therapeutics, Inc.Common StockTABUTEAU HERRIOTExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Axsome Therapeutics, Inc.AXSM · company listings
TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner
Exercise / conversionCommon StockNon-derivative security · Code M10,5588.02Value: 84,675.16Currency not specifiedView ↗
Trade: Axsome Therapeutics, Inc.AXSM · company listings
TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner
Exercise / conversionCommon StockNon-derivative security · Code M20,1638.02Value: 161,707.26Currency not specifiedView ↗
Trade: Axsome Therapeutics, Inc.AXSM · company listings
TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner
Exercise / conversionCommon StockNon-derivative security · Code M49,2528.02Value: 395,001.04Currency not specifiedView ↗
Trade: Axsome Therapeutics, Inc.AXSM · company listings
TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner
Exercise / conversionCommon StockNon-derivative security · Code M21,7758.02Value: 174,635.5Currency not specifiedView ↗
Trade: Axsome Therapeutics, Inc.AXSM · company listings
TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner
Exercise / conversionCommon StockNon-derivative security · Code M50,4598.02Value: 404,681.18Currency not specifiedView ↗
Trade: Axsome Therapeutics, Inc.AXSM · company listings
TABUTEAU HERRIOTChief Executive Officer · Director · 10% owner
Exercise / conversionCommon StockNon-derivative security · Code M91,7058.02Value: 735,474.1Currency not specifiedView ↗